<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="343051">
  <stage>Registered</stage>
  <submitdate>10/06/2011</submitdate>
  <approvaldate>10/06/2011</approvaldate>
  <actrnumber>ACTRN12611000603910</actrnumber>
  <trial_identification>
    <studytitle>Does scopolamine improve attention more than placebo in healthy volunteers and what does this tell us about mechanisms of attention?</studytitle>
    <scientifictitle>Does scopolamine improve selective attention and cognition more than placebo in healthy male volunteers?</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Normal attention and cognitive functioning</healthcondition>
    <conditioncode>
      <conditioncode1>Neurological</conditioncode1>
      <conditioncode2>Studies of the normal brain and nervous system</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Mental Health</conditioncode1>
      <conditioncode2>Studies of normal psychology, cognitive function and behaviour</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>A single dose of scopolamine (0.8mg contained in one capsule) 
(1-2 week washout between conditions)</interventions>
    <comparator>A single of dose of placebo (identical capsule) 
(1-2 week washout between conditions)</comparator>
    <control>Placebo</control>
    <interventioncode>Treatment: drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Attentional processing measured using an EEF paradigm quantifying Steady State Visual Evoked Potentials</outcome>
      <timepoint>Measured one hour after drug administration</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Spatial attention using a Contingent Capture task</outcome>
      <timepoint>Measured one hour after drug administration</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Nil</outcome>
      <timepoint>Nil</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Healthy volunteers
Aged 18-40 years
Male</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>40</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Males</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria>Current psychiatric or neurological diagnosis
Current use of psychotropic medication
Current use of cholinergic or anticholinergic medication
Medical condition in which scopolamine is contraindicated</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 4</phase>
    <anticipatedstartdate>20/06/2011</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>25</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Not yet recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>The University of Queensland</primarysponsorname>
    <primarysponsoraddress>Mark Bellgrove
The Queensland Brain Institute
Building #79, Upland Rd
The University of Queensland
St Lucia QLD 4072</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>University</fundingtype>
      <fundingname>The Queensland Brain Institute</fundingname>
      <fundingaddress>The Queensland Brain Institute
Building #79, Upland Rd
The University of Queensland
St Lucia, QLD 4072</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Attentional processing is a cognitive skill that allows us to interpret and act in our environment. Although this skill is important, little is understoond about the neurochemical processes that are important to attention. This study will allow us to assess the importance of different brain chemicals in contributing to selective attention function.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Angela Dean</name>
      <address>The Queensland Brain Institute
Building #79, Upland Rd
The University of Queensland
St Lucia QLD 4072</address>
      <phone>+61 7 3346 3325</phone>
      <fax />
      <email>a.dean@uq.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Angela Dean</name>
      <address>The Queensland Brain Institute
Building #79, Upland Rd
The University of Queensland
St Lucia QLD 4072</address>
      <phone>+61 7 3346 3325</phone>
      <fax />
      <email>a.dean@uq.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>